Eli Lilly is looking to approach regulators for approval of its once-weekly insulin for type 2 diabetes (T2D) after it proved ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III ...

Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute, helped deliver positive news for the estimated 7 million Americans who take ...

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...

Semaglutide improved time spent in glycemic range, time below rate and reduced body weight with low rates of hypoglycemia ...

Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, ...

One of the first brain cells shown to make insulin is the neurogliaform cell. These live in a brain area important for ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...

A new study published in the Journal of Ultrasound in Medicine ultrasound of one's thigh or shoulder muscle can help detect ...